UBS Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

UBS Group’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3	Closed	-$3K	–	8369
2015 Q4	$3K	Hold	3	–	–	﹤0.01%	7915
2015 Q3	$2K	Hold	3	–	–	﹤0.01%	8120
2015 Q2	$2K	Sell	3 -11	-79%	-$11.7K	﹤0.01%	8233
2015 Q1	$32K	Sell	14 -7	-33%	-$11.9K	﹤0.01%	6493
2014 Q4	$22K	Buy	+21	New	+$22.4K	﹤0.01%	7538

Other funds holding AMPE

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SWM

Sanctuary Wealth Management Pocatello, Idaho $151M AUM 17.94% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

UBS Group's AMPE Position: Q2 2024 in Review

UBS Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 1,246 shares — an estimated $1.15K sold.

UBS Group first reported a position in AMPE in Q4 2014 and held it in 37 quarters. The position peaked at $669K in Q1 2015. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.

UBS Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
UBS Group sold 1,246 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $1.15K.
UBS Group first reported a position in Ampio Pharmaceuticals Inc. in Q4 2014 and held it in 37 quarters.
UBS Group's Ampio Pharmaceuticals Inc. position peaked at $669K in Q1 2015.
6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.